BACKGROUND AND PURPOSE: Quantitative evaluation of midbrain atrophy may be useful
in differentiating progressive supranulear palsy (PSP) from Parkinson disease (PD); …

Rostral midbrain atrophy in progressive supranuclear palsy (PSP) is detected by mid-sagittal
plain magnetic resonance imaging (MRI). The shape of the atrophy looks like the bill of a …

Objective: To evaluate the area of the midbrain and pons on mid-sagittal MRI in patients with
progressive supranuclear palsy (PSP), Parkinson disease (PD), and multiple-system atrophy …

Anteroposterior diameters of the suprapontine midbrain, the pons, and the collicular plate
were measured in 50 patients with various parkinsonian syndromes (Parkinson disease …

BACKGROUND AND PURPOSE: Differential diagnosis of multiple system atrophy,
progressive supranuclear palsy, and corticobasal degeneration from Parkinson disease on …

Background The putaminal abnormalities detected on 1.5 T magnetic resonance imaging
(MRI), such as putaminal atrophy, slit-like hyperintense rim, and hypointensity in the …

Objective To compare the frequency and specificity of hypointense magnetic resonance
imaging (MRI) signal changes alone with the frequency and specificity of a pathological MRI …

Objectives: MRI-based measurements used to diagnose progressive supranuclear palsy
(PSP) typically lack pathologic verification and are not easy to use routinely. We aimed to …

Objectives–To assess midbrain atrophy through morphometric (linear, surface and
volumetric) measurements in patients with clinically diagnosed progressive supranuclear …

BACKGROUND: The objective of this study is to differentiate PSP from Parkinson's disease
through magnetic resonance imaging. METHODS: We included 14 consecutive patients with …